Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Trial of Cryosurgical Freezing and Multiplex Immunochemotherapy in Patients With Metastatic Solid Cancer

NCT04713371 is registered in ClinicalTrials.gov with Rampart Health, L.L.C. as lead sponsor.

NCT NCT04713371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04713371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Trial of Cryosurgical Freezing and Multiplex Immunochemotherapy in Patients With Metastatic Solid Cancer
Lead sponsor
Rampart Health, L.L.C.
Phase
Phase 2
Overall status
Unknown status
Start date
May 19, 2021
Completion date
December 31, 2024
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer